- ￥800 - 2500
- Sino Biological
- 北京
- 40588-T62
- 2025年09月19日
- WB,ELISA
- Rabbit
- 兔
企业认证
研选同类产品更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 用户评价
- 文献和实验
- 技术资料
- 免疫原：
Recombinant SARS-CoV-2 / 2019-nCoV Nucleocapsid Protein (Catalog#40588-V08B)
- 亚型：
Rabbit IgG
- 形态：
液体
- 保存条件：
在-20℃ to -80℃
- 克隆性：
PAb
- 适应物种：
兔
- 保质期：
12个月
- 抗原来源：
40588-V08B
- 目录编号：
40588-T62
- 级别：
免疫学试剂
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 宿主：
Rabbit
- 应用范围：
WB,ELISA
- 浓度：
WB: 1:1000-1:5000;ELISA: 1:5000-1:10000
- 靶点：
NP-CoV
- 抗体英文名：
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit PAb, Antigen Affinity Purified
- 抗体名：
新冠病毒 Nucleocapsid 兔多抗
- 规格：
20 µL/100 µL
| 规格： | 20 µL | 产品价格： | ￥800.0 |
|---|---|---|---|
| 规格： | 100 µL | 产品价格： | ￥2500.0 |
Coronavirus Nucleocapsid|Coronavirus Nucleocapsid antibody|Coronavirus Nucleocapsid抗体|Anti-2019-nCoV 兔多抗（产品说明）
抗体种属：2019-nCoV
抗体靶点：NP-CoV
抗体应用：WB,ELISA
抗原货号：40588-V08B;
抗原描述：Recombinant SARS-CoV-2 / 2019-nCoV Nucleocapsid Protein (Catalog#40588-V08B)
抗体宿主：Rabbit
抗体Ig类型：Rabbit IgG
抗体纯化方法：Protein A & Antigen Affinity
抗体制备：Produced in rabbits immunized with purified, recombinant SARS-CoV-2 / 2019-nCoV Nucleocapsid Protein (Catalog#40588-V08B; YP_009724397.2(335Gly/Ala); Met1-Ala419). The specific IgG was purified by SARS-CoV-2 / 2019-nCoV Nucleocapsid affinity chromatography.
抗体特异性：SARS-CoV-2 (2019-nCoV) NP Protein (Cat#40588-V08B)
抗体保存：This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
用户评价
暂无用户评价
文献和实验1, Wu Y, et al. RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation.Signal transduction and targeted therapy, PubMed ID: 33895773
2, Puray-Chavez M, et al. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.Cell reports, PubMed ID: 34214467
3, Zhang Q, et al. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.Nature communications, PubMed ID: 34244522
4, Wu K, et al. One-Step, Wash-free, Nanoparticle Clustering-Based Magnetic Particle Spectroscopy Bioassay Method for Detection of SARS-CoV-2 Spike and Nucleocapsid Proteins in the Liquid Phase.ACS applied materials & interfaces, PubMed ID: 34499464
5, Xu G, et al. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation.Cell research, PubMed ID: 34663909
6, Du S, et al. The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.Journal of virology, PubMed ID: 35045269
7, Jiang Y, et al. Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models.Cell discovery, PubMed ID: 35487885
8, Au GG, et al. Characterisation and natural progression of SARS-CoV-2 infection in ferrets.Scientific reports, PubMed ID: 35383204
9, Findlay-Wilson S, et al. Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins.Antiviral research, PubMed ID: 35533779
10, Puray-Chavez M, et al. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.mBio, PubMed ID: 35604092
11, Lonardi S, et al. Immunohistochemical Detection of SARS-CoV-2 Antigens by Single and Multiple Immunohistochemistry.Methods in molecular biology (Clifton, N.J.), PubMed ID: 35554913
12, Armando F, et al. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.Nature communications, PubMed ID: 35725735
13, Xu G, et al. Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2.Signal transduction and targeted therapy, PubMed ID: 36071039
14, Jin S, et al. Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.Nature communications, PubMed ID: 36057605
15, Zhao H, et al. Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay.New biotechnology, PubMed ID: 36423830
16, Gioia U, et al. SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence.Nature cell biology, PubMed ID: 36894671
17, Ryan KA, et al. Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.PLoS pathogens, PubMed ID: 37014911
18, Jiao P, et al. SARS-CoV-2 nonstructural protein 6 triggers endoplasmic reticulum stress-induced autophagy to degrade STING1.Autophagy, PubMed ID: 37482689
19, Abreu C, et al. Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner.Frontiers in immunology, PubMed ID: 37638023
20, Kawakami E, et al. Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19.Cell stem cell, PubMed ID: 37802037
21, Gartner MJ, et al. Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract.Med (New York, N.Y.), PubMed ID: 37769654
22, Puray-Chavez M, et al. A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models.bioRxiv : the preprint server for biology, PubMed ID: 38260460
23, Bannier-Hélaouët M, et al. Human conjunctiva organoids to study ocular surface homeostasis and disease.Cell stem cell, PubMed ID: 38215738
24, Clever S, et al. Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.Viruses, PubMed ID: 38543782
25, Antia A, et al. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.Viruses, PubMed ID: 38675974
技术资料暂无技术资料 索取技术资料
